Daniel I McIsaac: Less Blood Loss and No Excess VTE with Tranexamic Acid in High-Risk Surgery
Daniel I McIsaac, Professor and Vice Chair of Research and Innovation in Department of Anesthesiology and Pain Medicine at University of Ottawa, shared on LinkedIn about a recent article he and his colleagues co-authored, published in NEJM, adding:
”For every 100 patients having surgeries with >=5% risk of transfusion that you treat with tranexamic acid you save 16 units of red blood cells AND YOU DON’T INCREASE VTE RISK.”
Title: Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery
Authors: Brett L. Houston, Daniel I. McIsaac, Rodney H. Breau, Salmaan Kanji, Peter Greenstreet, Meghan Andrews, Sinziana Avramescu, Hema S. Bagry, Robert Balshaw, Jayesh Daya, Kaitlin Duncan, Christopher C. Harle, Eric Jacobsohn, Tina Kerelska, Marshall Pitz, Paul Komenda, Sarah McIsaac, Tim Ramsay, Tarit Saha, Alan Tinmouth, Angela Recio, Daniel Szoke, Marshall Tenenbein, Sarah Slagerman, Dayna Solvason, Robert Talarico, Dean A. Fergusson, Ryan Zarychanski
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 26, 2026, 14:45Sarah Giorgia Grazia Giannone: An Exciting Chapter in Gene Therapy Research
-
Jul 26, 2026, 14:21Javed Anees: Cerebral Collateral Circulation in Acute Ischemic Stroke
-
Jul 26, 2026, 14:11André Picard։ Canadian Blood Supplies Drop Sharply, Urgent Donor Appeal Issued
-
Jul 26, 2026, 13:54Lorenzo Scalia: New Review Highlights Anticoagulant Strategies for Elderly Patients With Atrial Fibrillation
-
Jul 26, 2026, 13:32Ahmed Kotb: A Practical Guide to Von Willebrand Disease
-
Jul 26, 2026, 12:42Emmanuel J Favaloro: Celebrating Excellence in Scientific Peer Review
-
Jul 26, 2026, 12:20Advancing Sickle Cell Care Through Advocacy – American Society of Hematology
-
Jul 26, 2026, 12:04Paolo Zamboni: Marking 50 Years in Medicine
-
Jul 26, 2026, 11:55William Wallace: Muscle Aging Emerges as the Strongest Mortality Predictor